## Note
nid: 1495821514207
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::#FirstAid::05_Pharmacology::03_Toxicities_&_Side_Effects::06_Drug_reactions_-_MSK/skin/connect_tissue, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::20_Erlotinib, #AK_Step1_v11::#OME_banner, #AK_Step1_v11::#Pixorize::02_Biochem::22_Onc_Drugs::21_Erlotinib, #AK_Step1_v11::#Pixorize::03_Pharm::11_Oncology::Erlotinib, #AK_Step1_v11::#SketchyPharm::08_Antineoplastics::03_Kinase_Inhibitors_&_Monoclonal_Antibodies::01_Imatinib,_erlotinib,_sorafenib,_sunitinib,_vemurafenib::zanki_extra, #AK_Step1_v11::^Other::^EXPN, #AK_Step1_v11::^Other::^HighYield::2-RelativelyHighYield
markdown: false

### Text
<div>
  Because the EGF receptor is expressed at the epidermis, Patients
  taking <b>Erlotinib</b> are at risk of
  <b>{{c1::Stevens-Johnson}}</b> <b>Syndrome</b>
</div>

### Extra
<img src="300px-Stevens-johnson-syndrome.jpg">
<div>
  <i>a man with Stevens-Johnsons syndrome</i>
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<img src="paste-37280316129283%20(1).jpg"><img src=
"paste-323204878958595.jpg"><img src=
"paste-326542068547587.jpg"><img src="paste-330222855520259.jpg">
<!--EndFragment-->

### Sketchy
<img src="paste-386186279387137.jpg" class="resizer"><img src=
"paste-6ef6236c9786ccaaf69cacfab716239d037e3c2e.png" class=
"resizer"> <a href=
"https://dashboard.sketchy.com/study/medical/courses/medical-pharmacology/units/medical-pharmacology-antineoplastics/videos/medical-pharmacology-antineoplastics-kinase-inhibitors-and-monoclonal-antibodies-imatinib-erlotinib-sorafenib-sunitinib-vemurafenib?utm_source=anki&utm_medium=partnership&utm_campaign=february_update&utm_content=medical">
Watch Imatinib, erlotinib, sorafenib, sunitinib, vemurafenib</a>

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_4.png"></a>
</div>

### Additional Resources
<img src=
"paste-f994ac31633b742158153fbf0fd1562da6722e5b.jpg"><img src=
"paste-0db76b35648ebfeebd07728e5a55d5821baca7d2.jpg"> <img src=
"big_547854aac3aa8.jpg">
<div>
  <div>
    Toxic epidermal necrolysis/Stevens-Johnson syndrome
  </div>
</div>
<div>
  <div>
    <div>
      This 6-month-old patient presents with toxic epidermal
      necrolysis, the severe form of Stevens-Johnson syndrome.
    </div>
    <div>
      Smallpox vaccination can trigger toxic epidermal necrolysis.
    </div>
  </div>
</div>
<div><img src="big_5272a95b8d359.jpg"></div>
<div>
  <div>
    <div>
      Stevens-Johnson syndrome following sulfonamide treatment
    </div>
  </div>
  <div>
    <div>
      <div>
        Blistering of skin and epidermal detachment involving the
        conjunctiva are visible, resembling a superficial burn.
      </div>
    </div>
  </div>
</div>

### One by one

